ACCENTIA BIOPHARMACEUTICALS INC 4
4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Jun 27, 2007
Insider Transaction Report
Form 4
Poole William
Director
Transactions
- Award
Stock Option
2007-06-25+6,666→ 20,000 totalExercise: $3.06From: 2007-06-25Exp: 2017-06-24→ Common Stock (6,666 underlying) - Award
Stock Option
2007-06-25+6,667→ 20,000 totalExercise: $3.06From: 2008-06-25Exp: 2017-06-24→ Common Stock (6,667 underlying)
Footnotes (2)
- [F1]Options terminate 10 years from grant date, or 90 days after the non-employee director ceases to be a director for any reason.
- [F2]Exercise price is 100% of fair market value on date of grant.